Skip to main content
Have a personal or library account? Click to login
The Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease Undergoing Hemodialysis Cover

The Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease Undergoing Hemodialysis

EABR. Experimental and Applied Biomedical Research
Volume 25 (2024): Issue 3 (September 2024)
By: ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Mar 2022
Figures & tables

Figures & Tables

Table 1.

Frequency of pathohistological categories of corpus mucosa in two study groups

CategoryHemodialysis patients n = 55Control patients n = 50χ2significance
Inflammation activityYes28 (50.9%)31 (62.5%)1.084p = 0.298
No27 (49.1%)19 (37.5%)
AtrophyYes23 (41.9%)8 (15%)7.274p = 0.007
No32 (58.1%)42 (85%)
Intestinal metaplasiaYes00––
No55 (100%)50 (100%)
Helicobacter pyloriYes28 (50.9%)22 (44%)0.315p = 0.574
No27 (49.1%)28 (56%)
Table 2.

Frequency of pathohistological categories of antrum mucosa in two study groups

CategoryHemodialysis patients n = 55Control patients n = 50χ2significance
Inflammation activityYes39 (72.1%)21 (42.5%)0.485p = 0.486
No16 (27.9%)29 (57.5%)
AtrophyYes24 (44.2%)21 (42.5%)0.024p = 0.877
No31 (55.8%)29 (57.5%)
Intestinal metaplasiaYes2 (4.7%)01.906p = 0.167
No53 (95.3%)50 (100%)
Helicobacter pyloriYes33 (60.6%)26 (52.5%)0.890p = 0.355
No22 (39.4%)24 (47.5%)
Table 3.

The relationships of HP presence and laboratory parameters

ParameterCorpus mucosaAntrum mucosa
Mean valuepMean valuep
Hemoglobin (g/dl)HP−10.47p = 0.26910.52p = 0.508
HP+10.8910.78
Creatinine (μmol/l)HP−1017.0p = 0.3941024.3p = 0.394
HP+963.64969.18
PTH (pg/ml)HP−473.73p = 0.537480.59p = 0.568
HP+396.87407.01
pHHP−7.310p = 0.1337.309p = 0.169
HP+7.3237.322
HCO3− (mmol/l)HP−13.70p = 0.03113.78p = 0.156
HP+14.7014.47
Dialysis duration (months)HP−91.10p < 0.001106.38p < 0.001
HP+31.6833.63
Kt/VHP−1.226p = 0.4471.199p = 0.765
HP+1.1901.213
Figure 1.

The prevalence of dyspeptic symptoms in hemodialysis patients and control subjects

Figure 2.

Endoscopic findings of the stomach in hemodialysis patients and control subjects

Figure 3.

Endoscopic findings of the duodenum in hemodialysis patients and control subjects

DOI: https://doi.org/10.2478/sjecr-2021-0044 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 225 - 232
Submitted on: Aug 2, 2021
Accepted on: Sep 28, 2021
Published on: Mar 22, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Chronic kidney disease,
dialysis,
Helicobacter pylori
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2022 Batric Babovic, Srdjan Djuranovic, Olgica Mihaljevic, Katarina Sakic, Jelena Borovinic Bojovic, Irena Radoman Vujacic, Natasa Belada Babovic, Vladimir Jovanovic, Nebojsa Zdravkovic, Vasilije Boskovic, Danilo Radunovic, Vladimir Prelevic, Ivica Petrovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 25 (2024): Issue 3 (September 2024)
Previous article
Next article